Research in Microbiology, published by Elsevier, is a prominent academic journal devoted to advancing the field of microbiology, encompassing a diverse array of topics including immunology, molecular biology, and biochemistry. Established in 1987, the journal has expanded its focus over the years, with a commendable impact factor reflecting its relevance and influence in the scientific community. Although it does not currently offer open access options, Research in Microbiology remains a crucial resource for researchers and professionals seeking to stay abreast of the latest findings and methodologies. The journal holds a respectable Q2 ranking in Medicine (miscellaneous) and a Q3 ranking in both Microbiology and Molecular Biology for 2023, highlighting its position within the scholarly landscape. With its base in France and accessible to a global audience, Research in Microbiology continues to foster scholarly exchange, making it an essential platform for the dissemination of impactful microbiological research.

MICROBIOLOGY AND IMMUNOLOGY, an esteemed journal published by WILEY, serves as a vital resource for researchers and professionals in the fields of microbiology, immunology, and virology. With its ISSN 0385-5600 and E-ISSN 1348-0421, this journal has been a cornerstone in scientific literature since its inception in 1977, bridging decades of research and innovation through its comprehensive coverage of emerging trends and discoveries. Although this journal operates without open access, it maintains a commendable presence in academic circles, reflected in its 2023 Quartile rankings of Q3 across the categories of Immunology, Microbiology, and Virology. As part of an important discourse in these disciplines, MICROBIOLOGY AND IMMUNOLOGY ensures its scholarly contributions are relevant to both seasoned researchers and emerging scholars. Positioned in a competitive journal landscape, with Scopus ranks indicating a median percentile across its fields, it remains committed to advancing knowledge through peer-reviewed articles, thereby supporting the continuous evolution of its focus areas. The journal's current scope encompasses topics critical for understanding pathogen-host interactions and the immune response, making it a crucial publication for any academic library or individual scholar dedicated to the biological sciences.

Medical Microbiology and Immunology is a renowned journal published by Springer, serving as a pivotal resource in the fields of microbiology and immunology. Established in 1971 and continuing its legacy through 2024, this journal features cutting-edge research and reviews that address critical advancements and challenges within these dynamic fields. With an impressive impact factor and a robust ranking, including Q1 categories in both Microbiology (medical) and Immunology, it stands at the forefront of scholarly communication, ranking 21st out of 140 in the realm of Medical Microbiology. Researchers and professionals are encouraged to explore a variety of studies that delve into the interactions between microorganisms and the immune system, making it an essential resource for anyone fascinated by these interconnected realms of health sciences. Although not open access, the journal is widely accessible through institutional libraries, ensuring that significant findings reach a global audience. The University of New York Plaza serves as its operational hub in the USA, reinforcing its international influence and dedication to advancing knowledge in microbiology and immunology.

APMIS is a distinguished academic journal published by WILEY that serves as a vital resource for researchers and practitioners in the fields of Immunology, Allergy, Microbiology, and Pathology. Established in 1988 and continuing its mission through 2024, this journal facilitates the dissemination of high-quality research findings, contributing to the intersection of multiple disciplines within the medical sciences. With an ISSN of 0903-4641 and an E-ISSN of 1600-0463, APMIS is categorized in 2023's Q2 and Q3 quartiles across various domains, reflecting its significant impact, with rankings such as #50/208 in Pathology and Forensic Medicine and #121/233 in Immunology and Allergy. Although it currently does not offer open access options, the journal’s rigorous peer-review process ensures that published articles maintain the highest standards of scholarship. With its focus on innovative research, APMIS continues to occupy a pivotal role for those seeking to advance their expertise and contribute to scientific dialogue in these essential fields.

Genes & Diseases, published by KEAI PUBLISHING LTD, is a premier open-access journal dedicated to advancing the fields of genetics, biochemistry, and molecular biology. Established in 2014 and headquartered in Beijing, China, this journal has quickly risen to prominence, securing a place in the prestigious Q1 quartile in Biochemistry and Genetics (clinical), as well as Q2 in Cell Biology and Q1 in Molecular Biology as of 2023. With a commitment to disseminating cutting-edge research, Genes & Diseases serves as a critical platform for researchers, professionals, and students alike, ensuring that high-quality scientific work is openly accessible to the global community. The journal's exceptional impact is underscored by its selective Scopus rankings, which reflect its influence and relevance in key scientific domains, making it an essential resource for those exploring the intersections of genetics and disease pathology.

Comparative Immunology Microbiology and Infectious Diseases, published by Elsevier Science Ltd, is a prominent journal dedicated to advancing the fields of immunology, microbiology, infectious diseases, and veterinary sciences. Established in 1978, this journal has become a vital resource for researchers and professionals alike, with a commendable impact factor that reflects its significance in academia. The journal, available in both print and electronic formats (ISSN: 0147-9571, E-ISSN: 1878-1667), stands out for its commitment to disseminating innovative research findings, particularly through its categorization in Q2 and Q3 quartiles across various related disciplines as of 2023. The journal aims to provide insightful comparative analyses that enhance our understanding of host-pathogen interactions, immune responses, and disease manifestations. With a global readership base, it serves as a platform for collaborative discourse among scientists and professionals, ultimately contributing to the improvement of health outcomes worldwide.

MICROBIOLOGICAL RESEARCH, published by Elsevier GmbH, serves as a leading platform for advancements in the field of Microbiology, holding an impressive Q1 ranking in its category as of 2023. With an ISSN of 0944-5013 and E-ISSN 1618-0623, this journal has been instrumental in disseminating high-quality research since its inception in 1994 and continues to contribute significantly to the academic landscape through 2024. Positioned within the top 13% of publications in the Immunology and Microbiology category, ranked #24 out of 182 according to Scopus, it attracts the attention of researchers, professionals, and students alike. While the journal is not open access, it offers vital insights and peer-reviewed articles that drive innovation and exploration within microbiological research. Its rigorous selection process underscores the importance of quality and relevance in advancing knowledge in this dynamic field.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, published by the American Society for Microbiology, is a premier journal dedicated to advancing the fields of microbiology and molecular biology. With an impressive impact factor reflective of its Q1 ranking in categories such as Immunology, Infectious Diseases, and Molecular Biology, this journal consistently showcases high-quality, peer-reviewed articles that contribute to the current understanding of microbial life and molecular mechanisms. Operating since 1997, the journal aims to bridge the gap between microbiological methods and molecular biology applications, making it an essential resource for researchers, professionals, and students alike. Readers can access content through various platforms, ensuring that the latest findings are readily available to the scientific community. With its esteemed reputation, MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS remains a leading voice in the exploration of the life sciences, catering to a broad audience deeply invested in unraveling the complexities of microbial and molecular systems.

Frontiers in Microbiology is a leading open-access journal published by Frontiers Media SA, available since 2010, and based in Switzerland. As a prominent platform for innovative research, it specializes in microbiology and medical microbiology, marked by its impressive Q1 classification in the respective fields, reflecting its significant impact and relevance in advancing microbial sciences. With a Scopus ranking of 49th in Microbiology and 41st in Medical Microbiology, this journal is positioned among the top-tier publications, catering to a diverse audience of researchers, professionals, and students. The journal aims to disseminate groundbreaking findings and foster discussions that drive the field forward, ensuring a comprehensive coverage of microbiological studies, from basic research to applications in healthcare and beyond. Enjoy unrestricted access to cutting-edge articles that contribute to both theoretical and applied aspects of microbiology, enriching the scientific community's knowledge base.

CURRENT OPINION IN MICROBIOLOGY is a prestigious academic journal published by CURRENT BIOLOGY LTD, dedicated to advancing the field of microbiology through timely and insightful reviews. With an ISSN of 1369-5274 and an e-ISSN of 1879-0364, this journal has established itself as a leading source of knowledge in various subfields, consistently achieving a Q1 ranking in Infectious Diseases and Microbiology for 2023. Operating from the United Kingdom, CURRENT OPINION IN MICROBIOLOGY serves a critical role for researchers, clinicians, and students alike by disseminating groundbreaking findings and fostering discussions that shape the future of microbiological research. The journal's rigorous selection process ensures that only high-quality articles are published, reflecting its strong impact factor and high percentile rankings across relevant Scopus categories. Although it does not follow an open-access model, its comprehensive scope and valuable contributions to the medical and scientific community underscore its importance as an essential resource for advancing our understanding of microbial sciences.